Literature DB >> 2737164

PTHrP secretion is stimulated by CT and inhibited by CgA peptides.

L J Deftos1, R Hogue-Angeletti, C Chalberg, S Tu.   

Abstract

We studied the regulation of the secretion in vitro of the parathyroid hormone-related protein (PTHrP) associated with the hypercalcemia of malignancy by Chromogranin A (CgA)-derived peptides and by human calcitonin (CT) in the BEN human lung tumor cell line. The amino terminal peptide of CgA, CgA1-40, inhibited the secretion of PTHrP, whereas other peptides had no such effect. Human CT stimulated the secretion of PTHrP, whereas other hormones had no such effect. Both effects occurred in a dose-dependent manner. These studies reveal novel regulatory pathways among peptides and proteins that are commonly associated with each other and can have paracrine interactions. CgA may be processed at its multiple dibasic sites to peptides that regulate the secretion of its co-resident hormones, in this case PTHrP. In addition to a paracrine effect, CT may be clinically useful as a provocative agent for PTHrP secretion. Complex interactions are present among the calcium-regulating hormones and their associated proteins.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2737164     DOI: 10.1210/endo-125-1-563

Source DB:  PubMed          Journal:  Endocrinology        ISSN: 0013-7227            Impact factor:   4.736


  10 in total

1.  The chromogranins and the counter-regulatory hormones: do they make homeostatic sense?

Authors:  J H Koeslag; P T Saunders; J A Wessels
Journal:  J Physiol       Date:  1999-06-15       Impact factor: 5.182

2.  Parathyroid Hormone-related Protein in Breast Cancer Tissues: Relationship between Primary and Metastatic Sites.

Authors: 
Journal:  Breast Cancer       Date:  1994-07-30       Impact factor: 4.239

3.  Immunohistochemicaf evidence of parathyroid hormone-related protein in human parathyroid tissue.

Authors:  Per Hellman; Gunnel Bjerneroth; Claes Juhlin; Peter Ridefelt; Jonas Rastad; Göran Åkerström; Harald Jüppner
Journal:  Endocr Pathol       Date:  1990-09       Impact factor: 3.943

4.  Large variations in the proteolytic formation of a chromogranin A-derived peptide (GE-25) in neuroendocrine tissues.

Authors:  R Kirchmair; B Leitner; R Fischer-Colbrie; J Marksteiner; R Hogue-Angeletti; H Winkler
Journal:  Biochem J       Date:  1995-08-15       Impact factor: 3.857

5.  Novel peptides from adrenomedullary chromaffin vesicles.

Authors:  J Sigafoos; W G Chestnut; B M Merrill; L C Taylor; E J Diliberto; O H Viveros
Journal:  J Anat       Date:  1993-10       Impact factor: 2.610

6.  Parathyroid hormone-like protein is a secretory product of atrial myocytes.

Authors:  L J Deftos; D W Burton; D W Brandt
Journal:  J Clin Invest       Date:  1993-08       Impact factor: 14.808

7.  A novel 1745-dalton pyroglutamyl peptide derived from chromogranin B is in the bovine adrenomedullary chromaffin vesicle.

Authors:  T Flanagan; L Taylor; L Poulter; O H Viveros; E J Diliberto
Journal:  Cell Mol Neurobiol       Date:  1990-12       Impact factor: 5.046

8.  Parathyroid hormone-related protein secretion is inhibited by oestradiol and stimulated by antioestrogens in KPL-3C human breast cancer cells.

Authors:  J Kurebayashi; H Sonoo
Journal:  Br J Cancer       Date:  1997       Impact factor: 7.640

9.  Effects of glucocorticoids and calcitonin on parathyroid hormone-related protein (PTHrP) gene expression and PTHrP release in human cancer cells causing humoral hypercalcemia.

Authors:  K Kasono; O Isozaki; K Sato; Y Sato; K Shizume; K Ohsumi; H Demura
Journal:  Jpn J Cancer Res       Date:  1991-09

Review 10.  The chromogranins A and B: the first 25 years and future perspectives.

Authors:  H Winkler; R Fischer-Colbrie
Journal:  Neuroscience       Date:  1992-08       Impact factor: 3.590

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.